Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 132, Issue 24
December 13 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

Lymphoid Neoplasia
New wrinkle on deubiquitination in B-cell lymphoma
Siegfried Janz
View Articletitled, New wrinkle on deubiquitination in B-cell lymphoma
Red Cells, Iron, and Erythropoiesis
Stressed about erythropoiesis: EBI macrophages
Malay Haldar
View Articletitled, Stressed about erythropoiesis: EBI macrophages
THROMBOSIS AND HEMOSTASIS
Of mice and men: genes relevant to thrombosis and bleeding
Paolo Gresele,Loredana Bury
View Articletitled, Of mice and men: genes relevant to thrombosis and bleeding

REVIEW ARTICLE

Mechanisms of receptor shedding in platelets
Samantha J. Montague,Robert K. Andrews,Elizabeth E. Gardiner
View Articletitled, Mechanisms of receptor shedding in platelets

CLINICAL TRIALS AND OBSERVATIONS

Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
Clinical Trials & Observations
Nizar J. Bahlis,Heather Sutherland,Darrell White,Michael Sebag,Suzanne Lentzsch,Rami Kotb,Christopher P. Venner,Cristina Gasparetto,Aldo Del Col,Paola Neri,Donna Reece,Michael Kauffman,Sharon Shacham,T. J. Unger,Jacqueline Jeha,Jean-Richard Saint-Martin,Jatin Shah,Christine Chen
View Articletitled, Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
Supplemental data
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
Clinical Trials & Observations
Laurent Garderet,Frederique Kuhnowski,Benoit Berge,Murielle Roussel,Martine Escoffre-Barbe,Ingrid Lafon,Thierry Facon,Xavier Leleu,Lionel Karlin,Aurore Perrot,Philippe Moreau,Gerald Marit,Anne-Marie Stoppa,Bruno Royer,Carine Chaleteix,Mourad Tiab,Carla Araujo,Pascal Lenain,Margaret Macro,Eric Voog,Lofti Benboubker,Olivier Allangba,Eric Jourdan,Frederique Orsini-Piocelle,Sabine Brechignac,Jean-Richard Eveillard,Karim Belhadj,Marc Wetterwald,Brigitte Pegourie,Arnaud Jaccard,Jean-Claude Eisenmann,Sylvie Glaisner,Mohamad Mohty,Cyrille Hulin,Herve Avet Loiseau,Claire Mathiot,Michel Attal
View Articletitled, Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
Supplemental data

LYMPHOID NEOPLASIA

UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice
Sajjad Hussain,Tibor Bedekovics,Qiuying Liu,Wenqian Hu,Haeseung Jeon,Sarah H. Johnson,George Vasmatzis,Danielle G. May,Kyle J. Roux,Paul J. Galardy
View Articletitled, UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice
Supplemental data

MYELOID NEOPLASIA

Unique dependence on Sos1 in KrasG12D-induced leukemogenesis
Brief Report
Xiaona You,Guangyao Kong,Erik A. Ranheim,David Yang,Yun Zhou,Jing Zhang
View Articletitled, Unique dependence on Sos1 in <em>Kras</em><sup><em>G12D</em></sup>-induced leukemogenesis
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Monocyte-derived macrophages expand the murine stress erythropoietic niche during the recovery from anemia
Chang Liao,K. Sandeep Prabhu,Robert F. Paulson
View Articletitled, Monocyte-derived macrophages expand the murine stress erythropoietic niche during the recovery from anemia
Supplemental data

THROMBOSIS AND HEMOSTASIS

A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding
e-blood
Constance C. F. M. J. Baaten,Stuart Meacham,Susanne M. de Witt,Marion A. H. Feijge,David J. Adams,Jan-Willem N. Akkerman,Judith M. E. M. Cosemans,Luigi Grassi,Steve Jupe,Myrto Kostadima,Nadine J. A. Mattheij,Martin H. Prins,Ramiro Ramirez-Solis,Oliver Soehnlein,Frauke Swieringa,Christian Weber,Jacqueline K. White,Willem H. Ouwehand,Johan W. M. Heemskerk
View Articletitled, A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding
Supplemental data

TRANSPLANTATION

Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia
Alice Bertaina,Marco Zecca,Barbara Buldini,Nicoletta Sacchi,Mattia Algeri,Francesco Saglio,Cesare Perotti,Anna Maria Gallina,Valentina Bertaina,Edoardo Lanino,Arcangelo Prete,Walter Barberi,Manuela Tumino,Claudio Favre,Simone Cesaro,Francesca Del Bufalo,Mimmo Ripaldi,Stella Boghen,Gabriella Casazza,Marco Rabusin,Adriana Balduzzi,Franca Fagioli,Daria Pagliara,Franco Locatelli
View Articletitled, Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia
Supplemental data

LETTER TO BLOOD

Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients
Romanos Sklavenitis-Pistofidis,Marzia Capelletti,Chia-Jen Liu,Mairead Reidy,Oksana Zavidij,Daisy Huynh,Patrick Henrick,Alexandra Savell,Kaitlen Reyes,Bradley Rivotto,Mark Bustoros,Adriana Perilla-Glen,Lorenzo Trippa,Jorge J. Castillo,Steven P. Treon,Irene M. Ghobrial
View Articletitled, Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

BLOOD WORK

Systemic mastocytosis with an associated hematological neoplasm masquerading as overt primary myelofibrosis
Rebecca Z. Xu,Zhaodong Xu
View Articletitled, Systemic mastocytosis with an associated hematological neoplasm masquerading as overt primary myelofibrosis

ERRATUM

Stahl A, Joyal J-S, Chen J, et al. SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood. 2012;120(14):2925-2929.
View Articletitled, Stahl A, Joyal J-S, Chen J, et al. SOCS3 is an endogenous inhibitor of pathologic angiogenesis. <em>Blood.</em> 2012;120(14):2925-2929.
All Issues

Advertisement intended for health care professionals

Mosunetuzumab next up to bat … is it a home run?
Novel CAR T cells to combat antigen escape in AML
Heme fuels venetoclax resistance in multiple myeloma
Introduction to a review series on mantle cell lymphoma: sands shifting in the darkness
Sequential epigenetic therapy in AML

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals